Histology-agnostic drug development - considering issues beyond the tissue.

Nature Reviews. Clinical Oncology
Roberto Carmagnani PestanaDavid S Hong

Abstract

With advances in tumour biology and immunology that continue to refine our understanding of cancer, therapies are now being developed to treat cancers on the basis of specific molecular alterations and markers of immune phenotypes that transcend specific tumour histologies. With the landmark approvals of pembrolizumab for the treatment of patients whose tumours have high microsatellite instability and larotrectinib and entrectinib for those harbouring NTRK fusions, a regulatory pathway has been created to facilitate the approval of histology-agnostic indications. Negative results presented in the past few years, however, highlight the intrinsic complexities faced by drug developers pursuing histology-agnostic therapeutic agents. When patient selection and statistical analysis involve multiple potentially heterogeneous histologies, guidance is needed to navigate the challenges posed by trial design. Additionally, as new therapeutic agents are tested and post-approval data become available, the regulatory framework for acting on these data requires further optimization. In this Review, we summarize the development and testing of approved histology-agnostic therapeutic agents and present data on other agents currently under develo...Continue Reading

References

Jul 1, 1992·Japanese Journal of Cancer Research : Gann·W WajjwalkuM Takahashi
Aug 1, 1995·The Journal of Experimental Medicine·M F Krummel, J P Allison
May 5, 1995·Science·R ParsonsB Vogelstein
Jul 15, 2005·The New England Journal of Medicine·Daniela S Krause, Richard A Van Etten
May 3, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michael C HeinrichUNKNOWN Imatinib Target Exploration Consortium Study B2225
Mar 18, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gunter von MinckwitzSibylle Loibl
Nov 4, 2009·Molecular and Cellular Endocrinology·A GrecoM A Pierotti
Apr 7, 2010·Nature Reviews. Clinical Oncology·Marc BuyseAimery de Gramont
Jul 29, 2010·The Journal of Clinical Investigation·Federica Di NicolantonioAlberto Bardelli
Jul 29, 2010·Virchows Archiv : an International Journal of Pathology·Josef RüschoffH H Kreipe
Jun 7, 2011·The New England Journal of Medicine·Paul B ChapmanUNKNOWN BRIM-3 Study Group
Apr 6, 2012·The Oncologist·Frans L OpdamJan H M Schellens
Oct 29, 2013·Nature Medicine·Aria VaishnaviRobert C Doebele
Mar 19, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Elizabeth A Mansfield
May 2, 2014·World Journal of Gastroenterology : WJG·Jan Trøst Jørgensen
Jun 25, 2014·Nature Reviews. Cancer·Matthew HolderfieldMartin McMahon
Sep 11, 2014·Nature Communications·Nicolas StranskyChristoph Lengauer
Nov 28, 2014·Nature·Matthew M GubinRobert D Schreiber
Dec 17, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lynnette Fernandez-Cuesta, Roman K Thomas
Dec 21, 2014·Cancer Discovery·Aria VaishnaviRobert C Doebele
Jan 8, 2015·The New England Journal of Medicine·Sara M TolaneyEric P Winer
Jan 28, 2015·Molecular Cancer·Michaela NelsonWilliam J Brackenbury
Feb 11, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Amanda J Redig, Pasi A Jänne
Feb 19, 2015·The New England Journal of Medicine·Sandra M SwainUNKNOWN CLEOPATRA Study Group
Apr 4, 2015·Science·Ton N Schumacher, Robert D Schreiber
Apr 9, 2015·World Journal of Gastroenterology : WJG·Alexandre A JácomeJosé Sebastião dos Santos
May 24, 2015·Cancer Letters·Laurent CréancierAnna Kruczynski
Jun 2, 2015·The New England Journal of Medicine·James LarkinJedd D Wolchok
Jun 2, 2015·The New England Journal of Medicine·Dung T LeLuis A Diaz
Aug 20, 2015·The New England Journal of Medicine·David M HymanJosé Baselga
Oct 16, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Scott KopetzLeonard Saltz
Nov 14, 2015·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Anna F FaragoAlice T Shaw
Nov 27, 2015·The Journal of Pathology·Monica BrencaRoberta Maestro

❮ Previous
Next ❯

Citations

Sep 19, 2020·Clinical Sarcoma Research·Paolo G CasaliAlessandro Gronchi
Nov 13, 2020·Pathologica·Marta SbaragliaAngelo P Dei Tos
Nov 11, 2020·Cancers·Mariona Baliu-PiquéAlberto Ocana
Mar 7, 2021·International Journal of Molecular Sciences·Jinsha LiuSepideh Afshar
Apr 16, 2021·BMC Medical Genomics·Mustafa ÖzdoğanGeorge Nasioulas
Jun 2, 2021·American Society of Clinical Oncology Educational Book·Razelle KurzrockDavid S Hong
Jun 3, 2021·JAMA Dermatology·Jennifer Y Wang, Kavita Y Sarin
May 16, 2021·Cancer Science·Hironobu MinamiKoshin Kiyohara
Oct 29, 2020·Archives of Pathology & Laboratory Medicine·Esther CondeFernando Lopez-Rios
Aug 28, 2021·Statistical Methods in Medical Research·Jie ZhouBrian P Hobbs
Nov 13, 2021·CA: a Cancer Journal for Clinicians·Paolo TarantinoGiuseppe Curigliano
Feb 8, 2022·Clinical Trials : Journal of the Society for Clinical Trials·Emily C ZaborBrian P Hobbs

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
GTPases

Software Mentioned

ESMO
SHIVA
TiFFANY
ESCAT

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Breast Cancer Research and Treatment
Paolo TarantinoGiuseppe Curigliano
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Cinta HierroElena Garralda
© 2022 Meta ULC. All rights reserved